Prediction of 30-day, 90-day, and 1-year mortality after colorectal cancer surgery using a data-driven approach

Karoline Bendix Bräuner(Zealand University Hospital Køge), Ismail Gögenür(University of Copenhagen), Ross D. Williams(Erasmus MC), Maliha Mashkoor(Zealand University Hospital Køge), Andreas Weinberger Rosen(Zealand University Hospital), Morten F. S. Hartwig(Zealand University Hospital Køge), Andi Tsouchnika(Zealand University Hospital Køge), Mustafa Bulut(Mustafa Kemal University), Peter Rijnbeek(Erasmus MC), Niclas Dohrn(Herlev Hospital)
International Journal of Colorectal Disease
February 29, 2024
10.1007/s00384-024-04607-w
Cited by 4

Related Papers

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
|British Journal of Cancer|2020|1.7k
Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study
|The Lancet Oncology|2014|477
The Safety of Melatonin in Humans
|Clinical Drug Investigation|2015|464
Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery
|JAMA Surgery|2023|434
Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation
|BMC Cancer|2019|362